AI Transparency Report
Mount Sinai Ambulatory Ventures Inc. demonstrates a unique financial profile, characterized by substantial assets and revenue, yet remarkably low reported expenses. For instance, in 2023, the organization reported over $4.6 million in revenue against only $7,428 in expenses, and similar patterns are observed across all reported periods. This discrepancy suggests that the organization's primary function might be as a holding entity or a pass-through for funds within a larger system (Mount Sinai), rather than directly incurring significant operational costs itself. While this structure isn't inherently negative, it makes a traditional assessment of spending efficiency challenging, as the true programmatic and administrative costs are likely borne by related entities. The consistent reporting of 0% officer compensation across all filings indicates a high degree of transparency regarding executive pay within this specific entity, though compensation for individuals within the broader Mount Sinai system would need to be examined elsewhere.
The organization's assets have shown consistent growth, from $7.4 million in 2014 to over $71 million currently, indicating strong financial accumulation. The very low reported expenses, particularly in relation to revenue, mean that almost all incoming funds are either retained or transferred, rather than spent on direct operations as typically understood for a nonprofit. This structure implies a high degree of financial stability for this specific entity, but also necessitates a broader understanding of its role within the Mount Sinai health system to fully evaluate its impact and financial health.